{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:30:11Z","timestamp":1775161811784,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T00:00:00Z","timestamp":1570924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.tcm.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T11:32:19Z","timestamp":1569929539000},"page":"378-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The subcutaneous implantable cardioverter defibrillator in 2019 and beyond"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3832-1518","authenticated-orcid":false,"given":"Vincent F","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas VA","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.tcm.2019.09.006_bib0001","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, cash and cids studies. antiarrhythmics vs implantable defibrillator study. cardiac arrest study hamburg. canadian implantable defibrillator study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.tcm.2019.09.006_bib0002","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"issue":"41","key":"10.1016\/j.tcm.2019.09.006_bib0003","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the Europe","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.tcm.2019.09.006_bib0004","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines and the Hea","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"issue":"16","key":"10.1016\/j.tcm.2019.09.006_bib0005","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.295.16.1901","article-title":"Pacemaker and ICD generator malfunctions: analysis of food and drug administration annual reports","volume":"295","author":"Maisel","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.tcm.2019.09.006_bib0006","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjcard.2012.11.052","article-title":"Predictors of mortality in patients with cardiovascular implantable electronic device infections","volume":"111","author":"Habib","year":"2013","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2019.09.006_bib0007","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.amjcard.2014.12.046","article-title":"Effects of tricuspid valve regurgitation on outcome in patients with cardiac resynchronization therapy","volume":"115","author":"Grupper","year":"2015","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2019.09.006_bib0008","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tcm.2019.09.006_bib0009","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/eurheartj\/ehv507","article-title":"The subcutaneous implantable cardioverter defibrillator: state-of-the-art review","volume":"38","author":"McLeod","year":"2017","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.tcm.2019.09.006_bib0010","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.tcm.2019.09.006_bib0011","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the effortless study","volume":"70","author":"Boersma","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2019.09.006_bib0012","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1540-8167.2011.02199.x","article-title":"Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the start study","volume":"23","author":"Gold","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.tcm.2019.09.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1111\/jce.13498","article-title":"Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: long-term complications, replacements, and battery longevity","author":"Quast","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"9","key":"10.1016\/j.tcm.2019.09.006_bib0014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11886-018-1021-8","article-title":"An overview of clinical outcomes in transvenous and subcutaneous ICD patients","volume":"20","author":"Baalman","year":"2018","journal-title":"Curr Cardiol Rep"},{"issue":"7","key":"10.1016\/j.tcm.2019.09.006_bib0015","first-page":"1010","article-title":"The learning curve associated with the introduction of the subcutaneous implantable defibrillator","volume":"18","author":"Knops","year":"2016","journal-title":"Eur Eur Pacing Arrhythmias Card Electrophysiol J Work groups Card Pacing Arrhythmias Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"10.1016\/j.tcm.2019.09.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2019.04.048","article-title":"Understanding outcomes with the S-ICD in primary prevention patients with low EF study (UNTOUCHED): clinical characteristics and perioperative results","author":"Boersma","year":"2019","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.tcm.2019.09.006_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pace.12994","article-title":"The design of the understanding outcomes with the s-icd in primary prevention patients with low EF study (UNTOUCHED)","volume":"40","author":"Gold","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"issue":"24","key":"10.1016\/j.tcm.2019.09.006_bib0018","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.tcm.2019.09.006_bib0019","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.hrthm.2017.05.016","article-title":"Subcutaneous implantable cardioverter-defibrillator post-approval study: clinical characteristics and perioperative results","volume":"14","author":"Gold","year":"2017","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.tcm.2019.09.006_bib0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ahj.2012.02.012","article-title":"Rationale and design of the praetorian trial: a prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous implantable cardioverter-defibrillator therapy","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J."},{"issue":"2","key":"10.1016\/j.tcm.2019.09.006_bib0021","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.hrthm.2015.09.007","article-title":"Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy","volume":"13","author":"Maurizi","year":"2016","journal-title":"Hear Rhythm"},{"issue":"8","key":"10.1016\/j.tcm.2019.09.006_bib0022","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.hrthm.2014.04.025","article-title":"Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator","volume":"11","author":"Groh","year":"2014","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.tcm.2019.09.006_bib0023","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.hrthm.2013.12.007","article-title":"Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management","volume":"11","author":"Kooiman","year":"2014","journal-title":"Heart Rhythm"},{"issue":"19","key":"10.1016\/j.tcm.2019.09.006_bib0024","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2012.06.053","article-title":"The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort","volume":"60","author":"Olde Nordkamp","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2019.09.006_bib0025","first-page":"1973","article-title":"Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis","volume":"19","author":"Auricchio","year":"2017","journal-title":"Eur Eur Pacing Arrhythmias Card Electrophysiol J Work groups Card Pacing Arrhythmias Card Cell Electrophysiol Eur Soc Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2019.09.006_bib0026","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jce.12612","article-title":"A new algorithm to reduce inappropriate therapy in the S-ICD system","volume":"26","author":"Brisben","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"10.1016\/j.tcm.2019.09.006_bib0027","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.hrthm.2018.05.011","article-title":"Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator","volume":"15","author":"Theuns","year":"2018","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.tcm.2019.09.006_bib0028","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10840-018-0459-3","article-title":"Remote monitoring of subcutaneous implantable cardioverter defibrillators","volume":"53","author":"De Filippo","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"issue":"3","key":"10.1016\/j.tcm.2019.09.006_bib0029","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/pace.13598","article-title":"A report on the impact of remote monitoring in patients with S-ICD: insights from a prospective registry","volume":"42","author":"Ninni","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.tcm.2019.09.006_bib0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hrthm.2007.11.018","article-title":"Complications associated with defibrillation threshold testing: the Canadian experience","volume":"5","author":"Birnie","year":"2008","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.tcm.2019.09.006_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.joa.2015.12.001","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"32","author":"Wilkoff","year":"2016","journal-title":"J Arrhythmia"},{"issue":"3","key":"10.1016\/j.tcm.2019.09.006_bib0032","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.hrthm.2018.09.029","article-title":"A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: the Praetorian score","volume":"16","author":"Quast","year":"2019","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.tcm.2019.09.006_bib0033","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacep.2016.12.026","article-title":"Novel extravascular defibrillation configuration with a coil in the substernal space: the ASD clinical study","volume":"3","author":"Chan","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.tcm.2019.09.006_bib0034","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.hrthm.2017.11.030","article-title":"Feasibility of extravascular pacing with a novel substernal electrode configuration: the substernal pacing acute clinical evaluation study","volume":"15","author":"Sholevar","year":"2018","journal-title":"Hear Rhythm"},{"issue":"2","key":"10.1016\/j.tcm.2019.09.006_bib0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jacep.2018.11.003","article-title":"Therapy from a novel substernal lead: the ASD2 study","volume":"5","author":"Boersma","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"10.1016\/j.tcm.2019.09.006_bib0036","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.hrcr.2015.07.009","article-title":"Combination of a leadless pacemaker and subcutaneous defibrillator: first in-human report","volume":"1","author":"Mondesert","year":"2015","journal-title":"HeartRhythm Case reports United States"},{"issue":"11","key":"10.1016\/j.tcm.2019.09.006_bib0037","first-page":"1866","article-title":"Device orientation of a leadless pacemaker and subcutaneous implantable cardioverter-defibrillator in canine and human subjects and the effect on intrabody communication","volume":"20","author":"Quast","year":"2018","journal-title":"Eur Eur Pacing Arrhythmias Card Electrophysiol J Work Groups Card Pacing Arrhythmias Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"10.1016\/j.tcm.2019.09.006_bib0038","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.jacc.2016.02.039","article-title":"Communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable defibrillator","volume":"67","author":"Tjong","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.tcm.2019.09.006_bib0039","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jacep.2017.04.002","article-title":"Acute and 3-Month performance of a communicating leadless antitachycardia pacemaker and subcutaneous implantable defibrillator","volume":"3","author":"Tjong","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.tcm.2019.09.006_bib0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00399-018-0602-y","article-title":"The modular cardiac rhythm management system: the empower leadless pacemaker and the EMBLEM subcutaneous ICD","volume":"29","author":"Tjong","year":"2018","journal-title":"Herzschrittmacherther Elektrophysiol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173819301355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173819301355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:59:18Z","timestamp":1760936358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173819301355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1050173819301355"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2019.09.006","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The subcutaneous implantable cardioverter defibrillator in 2019 and beyond","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}